Scarica l'app Stockscreener
48.01
1.24%
0.59
Pre-mercato:
47.80
-0.21
-0.44%
Precedente Chiudi:
$47.42
Aprire:
$47.43
Volume 24 ore:
2.32M
Relative Volume:
0.74
Capitalizzazione di mercato:
$9.09B
Reddito:
$2.83B
Utile/perdita netta:
$-1.02B
Rapporto P/E:
-8.7132
EPS:
-5.51
Flusso di cassa netto:
$194.14M
1 W Prestazione:
+4.12%
1M Prestazione:
+0.52%
6M Prestazione:
+1.27%
1 anno Prestazione:
-22.18%
Intervallo 1D:
$47.28
$48.41
Intervallo di 1 settimana:
$46.16
$48.41
Portata 52W:
$38.81
$72.83
Exact Sciences Corp Stock (EXAS) Company Profile
Nome
Exact Sciences Corp
Settore
Industria
Telefono
608-284-5700
Indirizzo
5505 ENDEAVOR LANE, MADISON, WI
Confronta EXAS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EXAS
Exact Sciences Corp
|
48.01 | 8.98B | 2.83B | -1.02B | 194.14M | -5.51 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-27 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-01-02 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-08-02 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-05-10 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-05-05 | Iniziato | UBS | Neutral |
| 2023-03-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-02-10 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-10-19 | Downgrade | Craig Hallum | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2021-11-03 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-07-29 | Reiterato | BTIG Research | Buy |
| 2021-07-29 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-29 | Reiterato | Oppenheimer | Outperform |
| 2021-07-29 | Reiterato | Stifel | Buy |
| 2021-06-15 | Iniziato | Raymond James | Strong Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-05-25 | Iniziato | Wells Fargo | Equal Weight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-29 | Downgrade | UBS | Buy → Neutral |
| 2020-10-28 | Downgrade | Citigroup | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-04-02 | Iniziato | Evercore ISI | Outperform |
| 2020-01-10 | Ripresa | BTIG Research | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Iniziato | Dougherty & Company | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-17 | Reiterato | BofA/Merrill | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-09-26 | Iniziato | Oppenheimer | Outperform |
| 2019-02-26 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-09-05 | Ripresa | The Benchmark Company | Hold |
| 2018-08-13 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-01-29 | Iniziato | Goldman | Neutral |
| 2018-01-08 | Reiterato | The Benchmark Company | Buy |
| 2017-11-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2017-11-01 | Downgrade | BTIG Research | Buy → Neutral |
Mostra tutto
Exact Sciences Corp Borsa (EXAS) Ultime notizie
Analyzing drawdowns of Exact Sciences Corporation with statistical toolsWeekly Stock Analysis & Community Consensus Picks - Newser
How to escape a deep drawdown in Exact Sciences CorporationForecast Cut & AI Driven Stock Movement Reports - Newser
Volume spikes in Exact Sciences Corporation stock – what they meanRate Cut & Low Risk Growth Stock Ideas - Newser
Can Exact Sciences Corporation be the next market leaderJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - خودرو بانک
Evaluating Exact Sciences Corporation with trendline analysisJuly 2025 Price Swings & Community Trade Idea Sharing Platform - Newser
Using data tools to time your Exact Sciences Corporation exitQuarterly Portfolio Report & Weekly Chart Analysis and Guides - Newser
Will Exact Sciences Corporation stock go up soonJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - Newser
Should I buy Exact Sciences Corporation stock nowJuly 2025 Drop Watch & Detailed Earnings Play Alerts - خودرو بانک
Will Exact Sciences Corporation outperform the marketJuly 2025 Opening Moves & Low Risk Investment Opportunities - Newser
What are the future prospects of Exact Sciences CorporationJuly 2025 Earnings & Safe Capital Allocation Plans - خودرو بانک
Developing predictive dashboards with Exact Sciences Corporation data2025 Top Gainers & Technical Confirmation Trade Alerts - Newser
How to read the order book for Exact Sciences CorporationTreasury Yields & AI Powered Market Entry Strategies - Newser
Is Exact Sciences Corporation stock forming a cup and handle2025 Bull vs Bear & Weekly Market Pulse Alerts - خودرو بانک
How Record Q2 Results and a New US$150 Million Savings Plan at Exact Sciences (EXAS) Have Changed Its Investment Story - Yahoo Finance
Exact Sciences Corporation’s volatility index tracking explained2025 Price Momentum & Expert Approved Trade Ideas - Newser
Is Exact Sciences Corporation stock entering bullish territoryJuly 2025 Action & Weekly Return Optimization Alerts - Newser
Applying Wyckoff theory to Exact Sciences Corporation stockWeekly Loss Report & Risk Managed Investment Strategies - Newser
Will breakout in Exact Sciences Corporation lead to full recoveryQuarterly Earnings Report & Long Hold Capital Preservation Plans - Newser
Real time scanner hits for Exact Sciences Corporation explainedJuly 2025 Selloffs & Consistent Income Trade Ideas - Newser
Historical volatility pattern of Exact Sciences Corporation visualized2025 Winners & Losers & Long-Term Growth Plans - Newser
Earnings visualization tools for Exact Sciences CorporationGap Up & Free High Accuracy Swing Entry Alerts - Newser
Combining price and volume data for Exact Sciences Corporation2025 Short Interest & Real-Time Volume Spike Alerts - Newser
Technical analysis overview for Exact Sciences Corporation stockMarket Performance Recap & Consistent Profit Alerts - Newser
Jefferies Reiterates a Buy Rating on Exact Sciences Corporation (EXAS) - Yahoo Finance
Published on: 2025-08-30 20:46:39 - Newser
Is Exact Sciences Corporation showing signs of accumulationTrade Exit Summary & Daily Growth Stock Tips - Newser
Should you wait for a breakout in Exact Sciences CorporationWeekly Stock Report & Community Consensus Stock Picks - Newser
What indicators show strength in Exact Sciences CorporationTrade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
What’s next for Exact Sciences Corporation stock priceBuy Signal & Community Verified Trade Alerts - Newser
Will Exact Sciences Corporation benefit from rising consumer demandJuly 2025 Sentiment & High Conviction Investment Ideas - sundaytimes.kr
Can Exact Sciences Corporation recover in the next quarter2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Predicting Exact Sciences Corporation trend using moving averagesProduct Launch & Stepwise Entry/Exit Trade Alerts - Newser
Is Exact Sciences Corporation stock reversal real or fakeTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - Newser
Is Exact Sciences Corporation stock a growth or value playIndex Update & Fast Exit/Entry Strategy Plans - Newser
Exact Sciences Corp Azioni (EXAS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.76%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):